Tags

Type your tag names separated by a space and hit enter

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Abstract

Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.

Links

  • Publisher Full Text
  • Authors

    Source

    MeSH

    Clinical Trials as Topic
    Consensus Development Conferences as Topic
    Consensus Development Conferences, NIH as Topic
    Female
    Humans
    Hyperandrogenism
    Insulin Resistance
    Luteinizing Hormone
    Polycystic Ovary Syndrome
    Risk Factors
    United States

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't
    Review

    Language

    eng

    PubMed ID

    14688154

    Citation

    Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. "Revised 2003 Consensus On Diagnostic Criteria and Long-term Health Risks Related to Polycystic Ovary Syndrome (PCOS)." Human Reproduction (Oxford, England), vol. 19, no. 1, 2004, pp. 41-7.
    Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.
    Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction (Oxford, England), 19(1), pp. 41-7.
    Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 Consensus On Diagnostic Criteria and Long-term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Hum Reprod. 2004;19(1):41-7. PubMed PMID: 14688154.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). A1 - ,, PY - 2003/12/23/pubmed PY - 2004/8/26/medline PY - 2003/12/23/entrez SP - 41 EP - 7 JF - Human reproduction (Oxford, England) JO - Hum. Reprod. VL - 19 IS - 1 N2 - Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events. SN - 0268-1161 UR - https://www.unboundmedicine.com/medline/citation/14688154/full_citation L2 - https://academic.oup.com/humrep/article-lookup/doi/10.1093/humrep/deh098 DB - PRIME DP - Unbound Medicine ER -